Marc David Benathen
CIK: 0001845258
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LFMD
LifeMD, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 22, 2025LFMD
LifeMD, Inc.
Award(A)Direct87K shares- - Jun 17, 2025LFMD
LifeMD, Inc.
Sale(S)Direct50K shares at avg. $14.01$700K - Jun 16, 2025LFMD
LifeMD, Inc.
Sale(S)Direct75K shares at avg. $13.09$982K - Mar 31, 2025LFMD
LifeMD, Inc.
Award(A)Direct75K shares- - Mar 7, 2025LFMD
LifeMD, Inc.
Award(A)Direct87K shares-
1-5 of 5 transactions
About Benathen Marc David
Benathen Marc David (SEC CIK 0001845258) files insider reports with the SEC as Chief Financial Officer of LifeMD, Inc. (LFMD).
Signal8 holds 4 ownership filings by Benathen Marc David, all Form 4s, filed between Mar 11, 2025 and Aug 26, 2025. Those filings report 5 transactions, from Mar 7, 2025 to Aug 22, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Benathen Marc David's filings is in NEW YORK, NY.
Recent filings by Benathen Marc David
- Aug 22, 2025: Grant or award of LFMD shares (Form 4, code A).
- Jun 17, 2025: Open-market sale of LFMD shares (Form 4, code S).
- Jun 16, 2025: Open-market sale of LFMD shares (Form 4, code S).
- Mar 31, 2025: Grant or award of LFMD shares (Form 4, code A).
- Mar 7, 2025: Grant or award of LFMD shares (Form 4, code A).
Other insiders filing for LifeMD, Inc. (LFMD)
- LAROVERE JOAN, Director
- Strawn John R Jr, Director
- DiTrolio Joseph, Director
- Simon Roberto, Director
- MACRAE CALUM ARCHIBALD, Director
- Sripad Umesh, Chief Technology Officer